Financial Daily from THE HINDU group of publications
Sunday, Feb 27, 2005
Financial Daily from THE HINDU group of publications Sunday, Feb 27, 2005 |
|
|
|
|
|
Corporate
-
Announcements Ranbaxy gets USFDA nod Our Bureau
NEW DELHI: Ranbaxy Laboratories Ltd has received tentative approval from the US Food and Drug Administration to manufacture and market donepezil hydrochloride tablets used for the treatment of mild to moderate dementia of the Alzheimer's type. The total market sales for donepezil hydrochloride tablets are estimated tobe at $935.3 million (Rs 4,000 crore). "This product represents a future opportunity and Ranbaxy will launch the tablets following final approval from the FDA," said Mr Jim Meehan, Vice-President of Sales and Marketing for Ranbaxy Pharmaceuticals Inc.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|